MIST
Milestone Pharmaceuticals Inc
Halal Rating :
Last Price
$1.97
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
28.76%
Company Overview
Industries
Exchange
Next Earnings Date
Milestone Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative cardiovascular medicines. Their lead product candidate is etripamil, a novel calcium channel blocker designed to provide rapid-onset and short-acting nasal spray treatment for paroxysmal supraventricular tachycardia (PSVT) and other cardiovascular conditions.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Milestone Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.